Soluble low-density lipoprotein receptor-related protein

Soluble low-density lipoprotein receptor-related protein (sLRP, LRP-515) is a biological substance naturally produced by the human body.[1][2] This protein has been found to bind to and neutralize anywhere from 70 to 90 percent of the amyloid-beta peptide that also naturally circulates in healthy human or mouse plasma.[3] Impairment of this function is strongly associated with, and may soon be shown definitively to be the principal cause of, Alzheimer's disease.[4]

References
  1. Quinn KA, Pye VJ, et al. (1999). "Characterization of the soluble form of the low density lipoprotein receptor-related protein (LRP)". Exp. Cell Res. 251 (2): 433–441. doi:10.1006/excr.1999.4590. PMID 10471328.
  2. Quinn KA, Grimsley PG, et al. (1997). "Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma". J. Biol. Chem. 272 (38): 23946–23951. doi:10.1074/jbc.272.38.23946. PMID 9295345.
  3. "Draining away brain's toxic protein to stop Alzheimer's". Retrieved 2007-10-25.
  4. Sagare A, Deane R, et al. (2007). "Clearance of amyloid-beta by circulating lipoprotein receptors". Nat. Med. 13 (9): 1029–1031. doi:10.1038/nm1635. PMC 2936449. PMID 17694066.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.